Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Usana Health Sciences (USNA) Accumulated Depreciation & Amortization (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Accumulated Depreciation & Amortization for 13 consecutive years, with $32.6 million as the latest value for Q1 2026.

  • Quarterly Accumulated Depreciation & Amortization rose 123.96% to $32.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $32.6 million through Jan 2026, up 123.96% year-over-year, with the annual reading at $32.6 million for FY2026, 123.96% up from the prior year.
  • Accumulated Depreciation & Amortization for Q1 2026 was $32.6 million at Usana Health Sciences, up from $14.5 million in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $32.6 million in Q1 2026, with the low at $12.7 million in Q4 2023.
  • Average Accumulated Depreciation & Amortization over 4 years is $17.2 million, with a median of $13.4 million recorded in 2022.
  • The sharpest move saw Accumulated Depreciation & Amortization dropped 5.17% in 2022, then surged 123.96% in 2026.
  • Over 4 years, Accumulated Depreciation & Amortization stood at $13.4 million in 2022, then decreased by 5.16% to $12.7 million in 2023, then grew by 14.46% to $14.5 million in 2024, then skyrocketed by 123.96% to $32.6 million in 2026.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $32.6 million, $14.5 million, and $12.7 million for Q1 2026, Q4 2024, and Q4 2023 respectively.